Novo Nordisk Launches Wegovy Weight Loss Pill in UAE, Expanding Beyond US Market
Danish pharmaceutical company Novo Nordisk has launched its weight loss pill Wegovy in the United Arab Emirates (UAE), marking its first international rollout outside of the U.S. The move is part of a broader strategy to expand globally as competition intensifies with rivals like Eli Lilly, whose Mounjaro recently overtook Ozempic for top-selling GLP-1 drug status.
